rosiglitazone has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrientos, MJ; Bueno, SM; González, PA; Gutiérrez, MA; Herrada, AA; Iruretagoyena, MI; Jacobelli, SH; Kalergis, AM; Leiva, ED; Riedel, CA | 1 |
| Bae, EH; Kim, IJ; Kim, SW; Lee, JU; Ma, SK; Park, JW | 1 |
| Bae, EH; Kim, IJ; Kim, SW; Ma, SK | 1 |
3 other study(ies) available for rosiglitazone and Bright Disease
| Article | Year |
|---|---|
Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus.
Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Diterpenes; Female; Glomerulonephritis; Hypoglycemic Agents; I-kappa B Proteins; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptors, IgG; Rosiglitazone; Thiazolidinediones | 2009 |
Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
Topics: Animals; Biomarkers; Blood Pressure; Blotting, Western; Desoxycorticosterone; Glomerulonephritis; Hypertension; Hypoglycemic Agents; Immunoenzyme Techniques; Inflammation; Male; Mineralocorticoids; Nephritis, Interstitial; PPAR gamma; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Sodium Chloride, Dietary; Thiazolidinediones | 2010 |
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
Topics: Animals; Cyclooxygenase 2; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Glomerulonephritis; HSP27 Heat-Shock Proteins; Hypertension; Kidney; Male; Nephritis, Interstitial; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1 | 2010 |